Letters to the Editor

Characterization of a novel MEF2D-BCL9 fusion positive acute lymphoblastic leukemia cell line

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands; Erasmus MC - Sophia Children's Hospital, Department of Pediatric Oncology and Hematology, Rotterdam, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands; Erasmus MC - Sophia Children's Hospital, Department of Pediatric Oncology and Hematology, Rotterdam, Netherlands
Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands
Haematologica Early view Apr 13, 2023 https://doi.org/10.3324/haematol.2022.281712